GLP-1R and Diabetes
US$ 25.26
gastroparesis glp-1 Drug-Induced and Product Liability Diabetic Gastroparesis and Glycaemic Control
Description
Emerging research suggests GLP-1 drugs like Ozempic, Wegovy, and Mounjaro may help reduce alcohol and substance cravings, offering a potential new treatment for addiction.
Results 76 eligible trials involving 15 GLP-1RA drugs and 39246 participants were included in this network meta-analysis
Eden | 1,873 followers on LinkedIn
GLP-1 receptor agonists, such as Ozempic (semaglutide), have gained significant attention in recent years for their impressive weight loss results
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
